Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 7201778574

Activities

Collapse all

Employment (4)

Juntendo University: Tokyo, JP

2021-04-01 to present | Specially Appointed Professor (Department of Brain Disease Translational Research)
Employment
Source: Self-asserted source
Koichi Ichimura

National Cancer Center Research Institute: Tokyo, JP

2011-10-01 to 2021-03-31 | Chief (Division of Brain Tumor Translational Research)
Employment
Source: Self-asserted source
Koichi Ichimura

University of Cambridge: Cambridge, Cambridgeshire, GB

1998-07-01 to 2011-06-30 | Senior Research Associate (Department of Pathology)
Employment
Source: Self-asserted source
Koichi Ichimura

Ludwig Institute for Cancer Research Stockholm Branch: Stockholm, SE

1996-07-01 to 1998-06-30 | Postdoctoral fellow (Clinical Group)
Employment
Source: Self-asserted source
Koichi Ichimura

Education and qualifications (2)

Karolinska Institutet: Stockholm, SE

1994-06-01 to 1996-06-30 | PhD (Faculty of Medicine) (Tumor Pathology)
Education
Source: Self-asserted source
Koichi Ichimura

Tokyo Medical and Dental University: Tokyo, JP

1979-04-01 to 1985-03-31 | MD (Faculty of Medicine)
Education
Source: Self-asserted source
Koichi Ichimura

Works (13)

KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway

Cancers
2023-12 | Journal article | Author
DOI: 10.3390/cancers16010009
Contributors: Takashi Fujii; Yoshiko Nakano; Daichi Hagita; Nobuyuki Onishi; Arumu Endo; Masaya Nakagawa; toruyukiko; Yohei Otsuka; Satoru Takeuchi; Mario Suzuki et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Adult intracranial ependymoma—relevance of DNA methylation profiling for diagnosis, prognosis, and treatment

Neuro-Oncology
2023-07-06 | Journal article
DOI: 10.1093/neuonc/noad030
Contributors: Malte Träger; Leonille Schweizer; Eilís Pérez; Simone Schmid; Elisabeth G Hain; Carsten Dittmayer; Julia Onken; Kohei Fukuoka; Koichi Ichimura; Ulrich Schüller et al.
Source: check_circle
Crossref

Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study

Cancers
2022-11-10 | Journal article
DOI: 10.3390/cancers14225522
Contributors: Motoo Nagane; Koichi Ichimura; Ritsuko Onuki; Daichi Narushima; Mai Honda-Kitahara; Kaishi Satomi; Arata Tomiyama; Yasuhito Arai; Tatsuhiro Shibata; Yoshitaka Narita et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort

Cancers
2022-02-15 | Journal article
DOI: 10.3390/cancers14040979
Contributors: Hirokazu Takami; Christopher S. Graffeo; Avital Perry; Caterina Giannini; Yoichi Nakazato; Nobuhito Saito; Masao Matsutani; Ryo Nishikawa; Koichi Ichimura; David J. Daniels
Source: check_circle
Crossref

MGMT testing always worth an emotion

Neuro-Oncology
2021-09-01 | Journal article
DOI: 10.1093/neuonc/noab163
Contributors: Monika E Hegi; Koichi Ichimura
Source: check_circle
Crossref

The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death

Cancer Science
2021-06 | Journal article
DOI: 10.1111/cas.14885
Contributors: Daisuke Kawauchi; Masamichi Takahashi; Kaishi Satomi; Shun Yamamuro; Tatsuya Kobayashi; Eita Uchida; Mai Honda‐Kitahara; Yoshitaka Narita; Yasuo Iwadate; Koichi Ichimura et al.
Source: check_circle
Crossref

Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma

Modern Pathology
2021-04 | Journal article
DOI: 10.1038/s41379-020-00701-w
Contributors: Kaishi Satomi; Makoto Ohno; Yuko Matsushita; Masamichi Takahashi; Yasuji Miyakita; Yoshitaka Narita; Koichi Ichimura; Akihiko Yoshida
Source: check_circle
Crossref

Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation

Cancers
2020-12 | Journal article | Author
DOI: 10.3390/cancers12123641
Contributors: Tatsuya Kobayashi; Makoto Miyazaki; Nobuyoshi Sasaki; Shun Yamamuro; Eita Uchida; Daisuke Kawauchi; Masamichi Takahashi; Yohei Otsuka; Kosuke Kumagai; Satoru Takeuchi et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis

Cancer Science
2018-07 | Journal article
DOI: 10.1111/cas.13635
Contributors: Ryohei Otani; Takeo Uzuka; Fumi Higuchi; Hadzki Matsuda; Masashi Nomura; Shota Tanaka; Akitake Mukasa; Koichi Ichimura; Phyo Kim; Keisuke Ueki
Source: check_circle
Crossref

Molecular pathogenesis of astrocytic tumours

Journal article
DOI:

10.1007/s11060-004-2747-2
Source: Self-asserted source
Koichi Ichimura

Molecular pathogenesis of IDH mutations in gliomas

Journal article
DOI:

10.1007/s10014-012-0090-4
Source: Self-asserted source
Koichi Ichimura

NF2 Methylation Is Rare in Sporadic Vestibular Schwannoma

Journal article
DOI:

10.1016/j.otohns.2010.06.170
Source: Self-asserted source
Koichi Ichimura

Replication Timing of Human Chromosome 6

Journal article
DOI:

10.4161/cc.4.1.1350
Source: Self-asserted source
Koichi Ichimura

Peer review (28 reviews for 4 publications/grants)

Review activity for Acta neuropathologica communications. (1)
Review activity for Acta neuropathologica. (19)
Review activity for Brain tumor pathology. (1)
Review activity for Neuro-oncology. (7)
How many people are using ORCID?